The 2018 Clemens von Pirquet Award for Clinical Research is awarded to Professor Joaquín Sastre who has significantly contributed to the progress of our understanding of airway allergy. Prof Sastre obtained his MD degree from Universidad Autónoma de Madrid in 1979, and subsequently conducted his residency in Allergology at the Allergy-Pulmonology Unit of the Fundación Jiménez Díaz in Madrid where he obtained his PhD in 1985. Thereafter he completed his training in Allergy and Clinical Immunology at Tulane University in New Orleans (USA). He worked in Hospital Universitario La Paz in Madrid and in the Research & Development department of the pharmaceutical company Montedison before becoming the Head of the Allergy Unit of the Fundación Jiménez Díaz in 1992. He served as the vice-president of the Latin-American Society of Allergy (1997-99), as member-at-large of the World Allergy Organization (1997-2007), as the Chair of EAACI Interest Group on Occupational Allergy (2003-2005), as board member of the Section on Environmental and Occupational Diseases of the American Academy of Allergy, Asthma, and Immunology, and as treasurer and then president (2014-2018) of the Spanish Society for Allergology and Clinical Immunology. Prof Sastre´s group is integrated in the Biomedical Research Center on Respiratory diseases (CIBERES) funded by the Spanish Ministry of Economy and Competitiveness.
Through his professional life, he has contributed to 400 abstracts presented at scientific conferences, and published 268 articles indexed in Pubmed, 87 of them in journals of the first quartile of the specialty. His research activities focus on airway allergy, especially on occupational diseases, and molecular allergology. Prof Sastre has also carried out many educational and teaching activities. He has given more than 300 invited talks, written 26 book chapters and directed seven PhD thesis. Moreover, under his leadership the Allergy Unit of Fundación Jiménez Díaz has established as one of the most reputed institutions in Spain to receive training in Allergology.
The 2018 Daniel Bovet Award for Treatment and Prevention is awarded to Professor Gideon Lack. He got his medical degree from Oxford University, got four years of training to become a pediatrician in New York and after that, over four years, specialized to pediatric allergy and immunology in Denver, Colorado. After specialization he worked as a lecturer of pediatrics in Bristol, after which he started in St Mary’s Hospital, London, in 1995. He led the Department of Pediatric Allergy and Immunology in St Mary’s for 12 years. He became Professor of Pediatric Allergy and Immunology at Imperial College, London, in 2005. From 2006 he has worked as Professor of Pediatric Allergy in King’s College and is Head of the Children’s Allergy Service at Guy’s and St Thomas’s NHS Foundation Trust and clinical lead in adult and pediatric allergy. Professor Lack has also established two allergy centers out of five in U.K. and he is a cofounder of the Allergy Academy at King’s College London.
His research has concentrated in childhood asthma and peanut allergy and, most importantly, on new strategies to prevent and treat food allergies, atopic dermatitis, asthma and allergic rhinoconjunctivitis in both children and adults. His early work already concentrated on the question of allergic sensitization and allergy prevention and now his LEAP (Learning Early About Peanut Allergy) and EAT (Enquiring About Tolerance) studies have changed the way we see allergy to start. Early introduction of foods to young children, as opposed to avoidance practiced earlier usually, reduced the amount of food allergy. These findings have significant repercussions on allergy prevention and treatment and pave way to handle the worldwide allergy epidemics seen today.
The 2018 Paul Ehrlich Award for Experimental Research is awarded to Professor Sebastian Johnston for his notable discoveries related to the viral aetiology of many asthma exacerbations, his decisive contribution in the discovering of novel mechanisms of susceptibility to virus infection in asthma, his leading role in the developing of the first mouse model of rhinovirus infection and rhinovirus-induced exacerbation of allergic airways inflammation, and the discovering of novel disease mechanisms, thereby helping develop novel treatment approaches for acute asthma exacerbations.
Sebastian Johnston is Professor of Respiratory Medicine & Allergy at the National Heart and Lung Institute, Imperial College London, and Honorary Consultant Physician in Respiratory Medicine & Allergy at St Mary's Hospital, Imperial Healthcare NHS Trust, London. He qualified from Guys Hospital in 1982, completed his PhD at the University of Southampton in 1993, and became professor in 1999 upon his move to Imperial College London.
Professor Sebastian Johnston is Director of the Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma, and recognized as world authority and key opinion leader in asthma exacerbations. He has been performing human virus challenge studies in asthma for more than twenty years and is the only investigator worldwide to have performed such studies in people with chronic obstructive pulmonary disease. With a long and productive history of collaborations with both the biotech and pharmaceutical industry, his work has led to more than 300 research publications in prestigious journals, the publishing of 12 patents, and the licensing of these patents to industry.
Professor Sebastian Johnston is committed to capacity build for academia, industry and health services by training new experimental and clinical investigators in asthma and COPD research, and, moreover, he is committed to playing a significant role in public engagement and communication in the public domain.
The 2018 Charles Blackey Award for Promotion of the Allergy Specialty is awarded to Professor Pascal Demoly. He is professor of Pulmonology at Montpellier University and head of Pulmonology Department at the University Hospital of Montpellier, France. He has had different position within the EAACi such as Vice-President or Education & Specialty. (2011-2015), President of the European Network for Drug Allergy (2003-2008), Associate Editor of Allergy journal (2010-2018) and Ga2len Member (since 2016).
He has done an important work on clinical guidelines for diagnosis and treatment of allergic diseases and standardization of procedures been since 2014 the co-chair Allergy in ICD-11, WHO International Classification of Diseases. Pascal Demoly has a longstanding track record in allergy and immunology research focused on allergen immunotherapy, drug allergy and respiratory diseases with more than 700 publications and H index of 78. He is a strong advocate for the implementation of a full medical specialty of allergology and clinical immunology throughout Europe.
The 2018 Daniel Bovet Award for Treatment and Prevention is awarded to Professor Gideon Lack. He got his medical degree from Oxford University, got four years of training to become a pediatrician in New York and after that, over four years, specialized to pediatric allergy and immunology in Denver, Colorado. After specialization he worked as a lecturer of pediatrics in Bristol, after which he started in St Mary’s Hospital, London, in 1995. He led the Department of Pediatric Allergy and Immunology in St Mary’s for 12 years. He became Professor of Pediatric Allergy and Immunology at Imperial College, London, in 2005. From 2006 he has worked as Professor of Pediatric Allergy in King’s College and is Head of the Children’s Allergy Service at Guy’s and St Thomas’s NHS Foundation Trust and clinical lead in adult and pediatric allergy. Professor Lack has also established two allergy centers out of five in U.K. and he is a cofounder of the Allergy Academy at King’s College London. His research has concentrated in childhood asthma and peanut allergy and, most importantly, on new strategies to prevent and treat food allergies, atopic dermatitis, asthma and allergic rhinoconjunctivitis in both children and adults. His early work already concentrated on the question of allergic sensitization and allergy prevention and now his LEAP (Learning Early About Peanut Allergy) and EAT (Enquiring About Tolerance) studies have changed the way we see allergy to start. Early introduction of foods to young children, as opposed to avoidance practiced earlier usually, reduced the amount of food allergy. These findings have significant repercussions on allergy prevention and treatment and pave way to handle the worldwide allergy epidemics seen today.
The 2018 Paul Ehrlich Award for Experimental Research is awarded to Professor Sebastian Johnston for his notable discoveries related to the viral aetiology of many asthma exacerbations, his decisive contribution in the discovering of novel mechanisms of susceptibility to virus infection in asthma, his leading role in the developing of the first mouse model of rhinovirus infection and rhinovirus-induced exacerbation of allergic airways inflammation, and the discovering of novel disease mechanisms, thereby helping develop novel treatment approaches for acute asthma exacerbations. Sebastian Johnston is Professor of Respiratory Medicine & Allergy at the National Heart and Lung Institute, Imperial College London, and Honorary Consultant Physician in Respiratory Medicine & Allergy at St Mary's Hospital, Imperial Healthcare NHS Trust, London. He qualified from Guys Hospital in 1982, completed his PhD at the University of Southampton in 1993, and became professor in 1999 upon his move to Imperial College London.
Professor Sebastian Johnston is Director of the Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma, and recognized as world authority and key opinion leader in asthma exacerbations. He has been performing human virus challenge studies in asthma for more than twenty years and is the only investigator worldwide to have performed such studies in people with chronic obstructive pulmonary disease. With a long and productive history of collaborations with both the biotech and pharmaceutical industry, his work has led to more than 300 research publications in prestigious journals, the publishing of 12 patents, and the licensing of these patents to industry.
Professor Sebastian Johnston is committed to capacity build for academia, industry and health services by training new experimental and clinical investigators in asthma and COPD research, and, moreover, he is committed to playing a significant role in public engagement and communication in the public domain.
The 2018 Charles Blackey Award for Promotion of the Allergy Specialty is awarded to Professor Pascal Demoly. He is professor of Pulmonology at Montpellier University and head of Pulmonology Department at the University Hospital of Montpellier, France. He has had different position within the EAACi such as Vice-President or Education & Specialty. (2011-2015), President of the European Network for Drug Allergy (2003-2008), Associate Editor of Allergy journal (2010-2018) and Ga2len Member (since 2016). He has done an important work on clinical guidelines for diagnosis and treatment of allergic diseases and standardization of procedures been since 2014 the co-chair Allergy in ICD-11, WHO International Classification of Diseases. Pascal Demoly has a longstanding track record in allergy and immunology research focused on allergen immunotherapy, drug allergy and respiratory diseases with more than 700 publications and H index of 78. He is a strong advocate for the implementation of a full medical specialty of allergology and clinical immunology throughout Europe.
EAACI Allergopharma Award 2019
Montserrat Fernandez- Rivas – Clemens von Pirquet Award for Clinical Research 
Susanne Halken – Daniel Bovet award for Treatment and Prevention 
Domingo Barber Hernández - Paul Ehrlich Award for Experimental Research
Nikolaos Papadopoulos - Charles Blackley Award for Promotion of the Allergy Specialty 
The 2017 Clemens von Pirquet Award for Clinical Research is awarded to Professor Miguel Blanca who has made an important contribution to the development of the specialty at both a national and international level. He is a specialist in allergy who trained at Malaga University Hospital University, and with a research stay at Middlesex University London. From 2000 to 2003 he was head of the allergy service, La Paz Hospital, and from 2003 to 2016 he was the head of the allergy department in the University Hospital of Malaga. From 2008 to 2016 Professor Blanca was coordinator of the National Network for the Study of Allergic Reactions to Drugs and Allergens (RIRAAF). He was also invited Professor at the University of Nancy (France). 
The 2017 Daniel Bovet Award for Treatment and Prevention is awarded to Professor Sten Dreborg. After finishing his specialisation in paediatrics at Uppsala Academic Hospital, Sten Dreborg served as head of the department of paediatrics, County Central Hospital, Boden, Sweden, from 1969-1979. During that time, he concentrated on organising paediatrics in the most northern county of Sweden, on neonatology, publishing the first Swedish CPAP publication, and on the Norrbottnian type of Gaucher’s disease, bringing about the first enzyme replacement by transplantation, and developing carrier and prenatal diagnosis. 
The 2017 Paul Ehrlich Award for Experimental Research is awarded to Professor Reto Crameri. After completing his bachelor’s, master’s and PhD degrees in 1981 at the Swiss Federal Institute of Technology (ETH) in Zürich, Reto Crameri moved to BiogenSA, Geneva, as senior scientist in molecular biology, where he stayed until 1986. Afterwards he worked at the Paul Scherrer Institute as principal investigator responsible for monitoring the natural radiation exposure of the Swiss population.
The 2017 Charles Blackey Award for Promotion of the Allergy Speciality is awarded to Professor Petr Panzner. He is professor and head of the department of immunology and allergology, faculty of medicine in Pilsen, Charles University in Prague. Petr Panzner is vice-president of the Czech Society of Allergology and Clinical Immunology, member of the managing board and a faculty member of the Czech Initiative for Asthma, and is editor-in-chief of Current Opinion in Allergy and Clinical Immunology - Czech and Slovak digest. 
The Charles Blackley Award 2015 for promotion of the specialty is awarded to Professor Luis Delgado. Professor Delgado, EAACI member 318, is Professor of Basic and Clinical Immunology and Head of the Department and Laboratory of Immunology, in the Faculty of Medicine, University of Porto, Portugal. He is a specialist in allergology and also serves as a Senior Consultant in allergology at the Allergy Department of the Centro Hospitalar São João, Porto, where he runs the immunology laboratory. Professor Delgado has had a remarkable career. Since his doctoral thesis on lung immunopathology presented in 1996, he has worked intensively within the research field of occupational and interstitial lung diseases, severe cutaneous drug eruptions, ocular allergy and allergy and asthma in sports practice. Within this scope, in 2001 he was the founder and chairman of the EAACI Interest Group on Allergy, Asthma and Sports. During the years immediately after, he chaired the Joint EAACI/ERS Task Force “Asthma and Allergic disorders in Sports” as well as the EAACI/AAAAI PRACTALL 2008: BASE initiative – “Bronchoconstriction, Allergy, Asthma in Sports and Exercise”. He is co-author of three books, sixteen chapters in textbooks, and more than one hundred clinical and research papers.Professor Delgado has contributed tremendously to the development of the specialty both on a national and international level. He served as a member of the Executive Board of the Portuguese Society of Allergy and Clinical Immunology from 1999 to 2007. Currently, he is President of the Society. From 2003 to 2011 he was a member of the EAACI Executive Committee. During this period, he was part of the CME Accreditation Committee and the ‘EAACI certified examination in allergology and clinical immunology’ Task Force. From 2009 to 2011, he was Vice-President for Education and Specialty, successfully managing, in a coordinated and innovative way, the Allergy Schools, educational outputs (Task Forces, monographs), knowledge test, and the collaborative structuring of the CME process with UEMS. Professor Delgado’s encouraging attitude, friendship, endless enthusiasm and far-reaching vision in the field of science and in life in general have been an inspiring force for generations of both clinicians and researchers.
The Paul Ehrlich Award 2015 for improving experimental research is awarded to Professor Wytske Fokkens. Wytske J. Fokkens is Professor and Chairman of the Department of Otorhinolaryngology at the Academic Medical Center in Amsterdam. Her main field of interest is sinus surgery and mucosal pathology of the upper and lower airways. She is the current President of the European Rhinologic Society (ERS) and the International Society of Infection and Allergy of the Nose (ISIAN). She is also the Chairman of the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS). Professor Fokkens is a member of the executive committees of ARIA and ERS, and work package and centre leader of GA2LEN, the EU network of excellence. She is the author of more than 300 papers on allergy and rhinology published in peer-reviewed journals. She has written a textbook on rhinology: Rhinology and Skull Base Surgery: From the Lab to the Operating Room – An Evidence Based Approach (Thieme). She serves as Editor-in-Chief of Rhinology and is Associate Editor of the Allergy and Clinical Respiratory Journals. She is married and has three children.
The Daniel Bovet Award for improving treatment and prevention of allergic diseases is awarded to Professor Marek Kowalski. Professor Marek L. Kowalski is Chair at the Department of Immunology, Rheumatology and Allergy, Faculty of Medicine and Director of the Healthy Ageing Research Center (HARC) at the Medical University in Lodz, from where he received medical and doctorate degrees. He has worked as a visiting scientist at the Department of Clinical Immunology and Allergy in London with Professor Barry Kay, and for three years (1986–1988) was a visiting fellow at the National Institute of Health in Bethesda, with Professor Michel Kaliner. He is board certified in internal medicine, allergology and clinical immunology.Professor Kowalski was a member of the EAACI Executive Committee (1998–2009) and EAACI Treasurer (2003–2009); in 2009, he was President of the 28th EAACI Congress held in Warsaw. He was also President of the Polish Society of Allergology (2003–2006), member of the World Allergy Organization Board of Directors (2008–2011) and Chair of the WAO Communications Council. He was the Associate Editor of Allergy (2001–2009) and is currently the Editor-in-Chief of Alergia Astma Immunologia and serves on editorial boards for several international journals (Allergy Asthma Immunology Research, Asthma Allergy Clinical Immunology, Allergy and Asthma Proceedings, Current Allergy and Asthma Reports), and he is the coordinator of the HARC 7FP RegPot Project (2013–2016), as well as partner in four EC funded IP projects (FAST, Predicta, MedAll and iFAAM). His major research interests include pathogenesis and management of bronchial asthma and COPD, immunology of respiratory infections, immunology of ageing, and hypersensitivity to NSAIDs. He has authored or co-authored more than 300 publications.Professor Kowalski has been honoured with several Polish and international awards, including the Order of Polonia Restituta, International Distinguished Fellowship Award of the American College of Allergy Asthma and Immunology, honorary membership of the Lithuanian Society of Allergology and Clinical Immunology, the Purkini Medal of the Czech Society of Clinical Immunology and Allergology, and honorary membership of the Hungarian Allergy and Immunology Society.
The Clemens von Pirquet Award 2015 for improving clinical research is awarded to Professor Anne Moneret-Vautrin. Denise Anne Moneret-Vautrin is Professor Emeritus of Allergology at the medical faculty of the Henri Poincaré Nancy University in Lorraine, France. She is the President of the Allergy Vigilance Network and a member of the prestigious French National Academy of Medicine. She is a dedicated internist, allergist and scientist, looking deep into the immunological mechanisms causing (food) allergic reactions, and providing information and support to improve the quality of life of the allergic patient. She has a longstanding track record in allergy research, mirrored by more than 380 papers listed in PubMed, and is a highly respected authority in France. Professor Moneret-Vautrin is also the founder of the Allergy Vigilance Network, which indexes cases of anaphylaxis, provides data on actual prevalence of food allergies, and implements post marketing surveillance of the allergic risk of foods. This first model of an anaphylaxis registry prompted clinicians in other countries to establish similar activities. As a true European, she recently joined forces with the German anaphylaxis registry to develop a European-wide registry, providing service for health-care specialists across Europe. Professor Moneret-Vautrin has trained more than one generation of clinicians and is still highly active investigating hot-topics in food allergy. She is well-known for tackling up-to-date topics, such as novel foods and new food products with allergenic risks, prompting a colleague to say: “Whenever you want to investigate new questions in food allergy, check first if it hasn’t already been published by Professor Moneret-Vautrin.”
The 2016 Charles Blackley Award for Promotion of the Specialty is awarded to Professor Dr Jan de Monchy. Jan de Monchy has worked in the field of allergology for many years. He registered as an allergologist in 1980 and in 1993 was appointed Head of the Department and Professor of Allergology at the Academic Hospital Groningen. He has a heart for patient care, education and science, and has trained fellows in allergology and published more than 180 publications. But above all, he has always been a strong advocate for our specialty. As Chairman of the Netherlands Society of Allergology he fought for the specialty and the position of allergologists in the Netherlands. Later, he broadened his scope to the international field and, in 2007, became UEMS President for the Allergology Section and Board; in that position he served EAACI as adjunct member of the Executive Committee for 8 years until June 2015. 
The 2016 Clemens von Pirquet Award for Clinical Research is awarded to Professor Magnus Wickman. Magnus Wickman has a long record of achievements in clinical research in the field of pediatric epidemiology, allergy and asthma research. He is a board certified pediatrician and pediatric allergologist with certified training in epidemiology at Karolinska Institutet, Stockholm, Sweden. He was one of the first scientists to study the natural history of allergic disorders, atopic dermatitis and asthma in childhood and adolescents in birth cohorts; he is well-known in the field. And is the author or co-author of more than 200 peer-reviewed publications. His work unites population-based medicine and epidemiology, clinical medicine (in particular food allergy), molecular allergology and genetics/epigenetics and brings together senior investigators and health professionals from multiple disciplines from a regional, national but also an international level. Magnus has stimulated numerous PhD students to write and finish their theses and to make them part of the scientific world. His strength is always to challenge old beliefs and to bring out the best in research projects.
The 2016 Daniel Bovet Award for improving treatment and prevention of allergic diseases is awarded to Professor Erkka Valovirta. Erkka Valovirta, MD, PhD, is a pediatric allergist who has dedicated his life and career in Turku, Finland, to work with children suffering from allergic diseases. Alongside his clinical work, he has also been affiliated with the University of Turku as a lecturer and was made Professor honoris causa in 2010.
The 2016 Paul Ehrlich Award for Improving Experimental Research is awarded to Professor Dr Cezmi Akdis, MD. Cezmi Akdis is the Director of the Swiss Institute of Allergy and Asthma Research (SIAF), Davos, and Professor in the Zurich University Medical Faculty, as well as being one of the Directors of the Christine Kühne Center for Allergy Research and Education (CK-CARE) in Davos. 
The Charles Blackley Award 2014 for the Promotion of the Specialty is awarded to Professor Jan Lotvall. Professor Jan Lötvall is Professor of Clinical Allergology in Gothenburg, Sweden, and has been a leading researcher in the field of asthma since the late-1980s. He is currently the chairman of the Krefting Research Centre at the University of Gothenburg, where his focus is asthma phenotypes, endotypes and severity. He is also a leader in the field of extracellular vesicles, and led the breakthrough research showing that exosomes can shuttle functional RNA molecules between cells, which was published in Nature Cell Biology in 2007, and is the most cited publication in the field. Additonally, Jan Lötvall was Secretary General of EAACI from 2005-2009 before being elected EAACI President from 2009-2011. During this six year period, EAACI saw healthy growth and was efficiently transformed from an association run almost exclusively by enthusiastic members, to an organization with its own staff and headquarters. He also organised several EAACI Allergy Schools, and the successful 2007 EAACI Congress in Gothenburg. During his mandate as a member of the EAACI Executive Committee he enthusiastically empowered JMA’s, worked tirelessly for the harmonization of the allergy specialty in Europe and established an ambitious project to develop collaboration among major allergy societies. This culminated in the International Collaboration in Asthma, Allergy and Immunology (iCAALL) which has delivered several International Consensus Statement (ICONs) publications on a range of clinical topics in allergy, to support efficient management of allergic diseases internationally. He is a fervent believer in a healthy-lifestyle, and radiates an extraordinarily passionate and warm personality, for which he is known in EAACI as the “most Latin of all Scandinavians”.
The Paul Ehrlich Award 2014 for Improving Experimental Research is awarded to Professor Hannah Gould. Hannah Gould is Professor Emeritus of Biophysics and Principal Investigator in the Allergy and Asthma Group in the Randall Division of Cell and Molecular Biophysics at King's College London, part of the MRC & Asthma UK Centre in the Allergic Mechanisms of Asthma. She also forms part of the Division of Asthma, Allergy and Lung Biology at the College. 
The Daniel Bovet Medal for improving treatment and prevention of allergic diseases is awarded to Professor Bodo Niggemann for his lifelong commitment to prevention, diagnosis and treatment of allergic diseases in children. Professor Niggemann is professor of pediatric allergology at Charité in Berlin, Germany and currently heads the division of pneumology and allergology in the department of pediatrics.
The Clemens von Pirquet Award for Improving Clinical Research is awarded to Professor Ronald Dahl. Professor Dahl is a specialist in both allergology and in pulmonary medicine, and is currently Professor of Clinical Allergology at the University of Southern Denmark. He also serves as a consultant in allergology at the affiliated Odense University Hospital, where he is in the process of establishing the Centre for Eosinophilic Disorders. He previously served as Professor of Respiratory Diseases at Aarhus University where he ran a large Clinic of Allergy and Lung Diseases at the affiliated Aarhus University Hospital.
The 2013 Charles Blackley Award for improving the Promotion of the Specialty is awarded to Professor François-Bernard Michel. From 1972 to 2000 François-Bernard Michel, professor of pulmonology, established and led a strong department dedicated to respiratory diseases, particularly for asthma and allergies, at the University Hospital of Montpellier, France. He has developed a school of clinicians and researchers of reference, recognised around the world. He organised the Congress of Paris in 1992 and become President of EAACI in the same year until 1995. Passionate about art and literature, he has published several books devoted to testimonies and analyses of artists vis-a-vis their disease such as Marcel Proust, Paul Valéry, Raymond Queneau and Van Gogh… alongside some other novels and poems. In 1998, he became a regular member of the French Academy of Medicine which he has chaired since 2013. In March 2000 Professor François-Bernard Michel was elected to the French Academy of the Fine Art, which he chaired in 2006 and 2012.
The 2013 Clemens von Pirquet Award for improving Clinical Research is awarded to Professor Martin K. Church. Martin K. Church has made substantial contributions to the understanding of allergic disease of the skin, nose and eye. He developed a rat model of anaphylactic bronchoconstriction that was widely used to test drugs for anti-allergic reactions and pioneered techniques for isolating and purifying mast cells from human tissues. He has extrapolated his work into a clinical environment by collaborating with clinicians. Prof. Church has developed dermal microdialysis and scanning laser Doppler imaging of the skin and is Professor of Immunopharmacology at the Charité Universitätsmedizin, Berlin, working on mechanisms and pharmacological treatments of urticaria and Emeritus Professor of Experimental Immunopharmacology at the University of Southampton, UK.
The 2013 Daniel Bovet Award for improving Treatment and Prevention is awarded to Professor Claude Molina. Claude Molina was born in Algeria in 1924 and was appointed Medical Doctor of Alger Hospitals in 1952, and head of the Pulmonology Dept. in 1961. Gaining a professorship in Pulmono-Phtisiology as early as 1958, he was transferred after the independence of the country in 1962 to Clermont Ferrand where he was to stay for 30 years. Claude Molina is “the precipitins man”. With Jack Pepys, his work and research made of him the leading European expert in the field of Hypersensitivity Pneumonitis and also addressed the issue of inflammation in Asthma. His passion for Education and Prevention led him being elected as President of the French Committee against Tuberculosis and Respiratory diseases in 1988. After having organised the EAACI Congress in Clermont Ferrand in 1981, he actively presided over the institution from 1983 to 1986. Under his presidency the number of members doubled and the working groups improved strongly with the creation of post graduate courses and the Audio Visual & Editorial Sub Committee which he chaired until 1995. As Emeritus Professor, he retired in 1992. Just as active as before, he developed with Franz Marrache the Bibliography Updates in Allergology, still published monthly on the Academy website.
The 2013 Paul Ehrlich Award for improving Experimental Research is awarded to Prof. Monique Capron. Monique Capron, Professor at Institute Pasteur and Professor of Immunology at the Faculty of Pharmacy in Lille, France, has achieved many outstanding contributions in the field of allergy and parasitology. Her scientific carrier has focused on the interface between these research area’s leading to a better understanding of the function of IgE and IgA, as well as their receptors on inflammatory cells, most notably eosinophils. Prof. Monique Capron also demonstrated that eosinophils have immunomodulatory functions via the release of several cytokines. She has authored over 300 scientific publications and been awarded numerous prestigious distinctions during her career. Prof Capron is a member of several learned societies.
The winner of the 2016 PhARF Award was announced on Saturday, June 11 at the opening ceremony of this year’s EAACI. Prof Antonella Muraro, President of EAACI, presented the PhARF statue (in the form of an IgE molecule) to Verena Niederberger-Leppin, MD, Assoc Prof, Department of Otorhinolaryngology, Medical University of Vienna, Austria.
The winner of the PhARF Award 2015 is Joshua David Milner, MD, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, US. It was announced at the Opening Ceremony of the EAACI Congress in Barcelona 6 June.
EAACI Allergopharma Award 2018
Presented at EAACI Congress 2017 in Helsinki, on 17 June 2017 to the winner, Kristina Britt Charlotte Johansson, MSc, PhD candidate:
Presented at EAACI in Vienna, the 11th of June 2016 to the winner, Dr. Irisz Karolina Levai:
Presented at EAACI in Barcelona, the 7th of June 2015 to the winner, Dr. Alexander Eggel, based on the article 
Lina Jankauskaité (Lithuania) won the EAACI Clinical Fellowship Award. She spent three months at the Charité Campus Virchow-Klinikum in Berlin, Germany, in autumn 2011.
Anca Mirela Chirac (Romania) won the EAACI Clinical Fellowship Award. She spent three months at the University Hospital of Montpellier, France, in summer 2011.
Roman Fishchuk (Ukraine) was awarded the EAACI Short Term Research Fellowship Award. During autumn 2011, he joined the Faculty of Medicine and Health Sciences in Ghent, Belgium.
The Daniel Bovet Award 2012 for improving Treatment and Prevention was awarded to Dr. Arne Host.
